Table 1

Lymphocyte populations in AU patients and controls

AU patients (n=146)Controls (n=31)p Value
Lymphocytes (no/mm3)2425.60 (964.44)2567.74 (820.72)NS
CD3 (no/mm3)1734.20 (726.67)1835.64 (586.68)NS
(%)71.96 (8.20)71.27 (4.28)NS
CD4 (no/mm3)1023.91 (489.16)1219.70 (427.56)<0.05
(%)42.56 (9.50)47.00 (6.13)<0.05
CD8 (no/mm3)702.21 (359.67)675.90 (243.54)NS
(%)29.25 (8.81)26.72 (6.81)NS
CD4/CD81.70 (0.89)1.92 (0.78)NS
CD19 (no/mm3)266.87 (227.44)335.90 (142.35)NS
(%)10.81 (5.65)13.64 (5.09)<0.05
CD4CD45R+ (no/mm3)406.17 (304.18)657.70 (301.36)<0.001
(%)16.70 (9.99)25.20 (7.76)<0.001
CD4CD45R- (no/mm3)661.53 (338.48)529.41 (219.04)<0.05
(%)27.70 (7.94)20.77 (6.40)<0.001
NK (no/mm3)300.45 (179.63)323.80 (182.53)NS
(%)13.30 (7.76)12.81 (5.86)NS
  • AU = anterior uveitis, NK = natural killer cells, NS = not significant. Data shown as mean (SEM).